A double-blind, placebo-controlled, randomised, multi-centre, phase III study of MLC901 (neuroaid) for the treatment of cognitive impairment after mild traumatic brain injury

Pavel I. Pilipenko,Anna A. Ivanova, Yulia V. Kotsiubinskaya,Vera N. Grigoryeva, Alexey Y. Khrulev, Anatoly V. Skorokhodov, Min Grigorievich Omelianenko, Maxim M. Gavrik, Nona N. Mkrtchan,Marek Majdan, Peter Valkovic,Daria Rabarova,Suzanne Barker-Collo,Kelly Jones,Valery Feigin

Journal of the Neurological Sciences(2023)

引用 0|浏览5
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要